In agreement with these findings, the overexpression of SirT1 has been shown to improve NAFLD [185] and conversely, SirT1 knockout mice have been shown to develop NAFLD [186]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.